» Articles » PMID: 34322375

Preoperative Prediction of Lymphovascular Space Invasion in Cervical Cancer With Radiomics -Based Nomogram

Overview
Journal Front Oncol
Specialty Oncology
Date 2021 Jul 29
PMID 34322375
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To build and evaluate a radiomics-based nomogram that improves the predictive performance of the LVSI in cervical cancer non-invasively before the operation.

Method: This study involved 149 patients who underwent surgery with cervical cancer from February 2017 to October 2019. Radiomics features were extracted from T2 weighted imaging (T2WI). The radiomic features were selected by logistic regression with the least absolute shrinkage and selection operator (LASSO) penalty in the training cohort. Based on the selected features, support vector machine (SVM) algorithm was used to build the radiomics signature on the training cohort. Incorporating radiomics signature and clinical risk factors, the radiomics-based nomogram was developed. The sensitivity, specificity, accuracy, and area under the curve (AUC) and Receiver operating characteristic (ROC) curve were calculated to assess these models.

Result: The radiomics model performed much better than the clinical model in both training (AUCs 0.925 0.786, accuracies 87.5% 70.5%, sensitivities 83.6% 41.7% and specificities 90.9% 94.7%) and testing (AUCs 0.911 0.706, accuracies 84.0% 71.3%, sensitivities 81.1% 43.4% and specificities 86.4% 95.0%). The combined model based on the radiomics signature and tumor stage, tumor infiltration depth and tumor pathology yielded the best performance (training cohort, AUC = 0.943, accuracies 89.5%, sensitivities 85.4% and specificities 92.9%; testing cohort, AUC = 0.923, accuracies 84.6%, sensitivities 84.0% and specificities 85.1%).

Conclusion: Radiomics-based nomogram was a useful tool for predicting LVSI of cervical cancer. This would aid the selection of the optimal therapeutic strategy and clinical decision-making for individuals.

Citing Articles

Risk factors for pelvic lymph node metastasis in cervical cancer: a retrospective analysis of 186 patients.

Sun X, He L, Wang S Front Oncol. 2025; 15:1525946.

PMID: 39959672 PMC: 11825327. DOI: 10.3389/fonc.2025.1525946.


Preoperative magnetic resonance imaging-radiomics in cervical cancer: a systematic review and meta-analysis.

Wu L, Li S, Li S, Lin Y, Wei D Front Oncol. 2024; 14:1416378.

PMID: 39026971 PMC: 11254676. DOI: 10.3389/fonc.2024.1416378.


Multiparametric mri-based radiomics nomogram for predicting lymph-vascular space invasion in cervical cancer.

Liu F, Zhao X, Zhang X, Zhao M, Lu S BMC Med Imaging. 2024; 24(1):167.

PMID: 38969972 PMC: 11225404. DOI: 10.1186/s12880-024-01344-y.


A nomogram of preoperative indicators predicting lymph vascular space invasion in cervical cancer.

Guo Q, Gao Y, Lin Y, Li W, Zhang Z, Mao Y Arch Gynecol Obstet. 2024; 309(5):2079-2087.

PMID: 38358484 DOI: 10.1007/s00404-024-07385-6.


Profiling of Lymphovascular Space Invasion in Cervical Cancer Revealed PI3K/Akt Signaling Pathway Overactivation and Heterogenic Tumor-Immune Microenvironments.

Choi Y, Ando Y, Lee D, Kim N, Lee O, Cho J Life (Basel). 2023; 13(12).

PMID: 38137942 PMC: 10744523. DOI: 10.3390/life13122342.


References
1.
Gillies R, Kinahan P, Hricak H . Radiomics: Images Are More than Pictures, They Are Data. Radiology. 2015; 278(2):563-77. PMC: 4734157. DOI: 10.1148/radiol.2015151169. View

2.
Tierney K, Lin P, Amezcua C, Matsuo K, Ye W, Felix J . Cervical conization of adenocarcinoma in situ: a predicting model of residual disease. Am J Obstet Gynecol. 2013; 210(4):366.e1-366.e5. DOI: 10.1016/j.ajog.2013.12.030. View

3.
Schorge J, Molpus K, Koelliker D, Nikrui N, Goodman A, Fuller Jr A . Stage IB and IIA cervical cancer with negative lymph nodes: the role of adjuvant radiotherapy after radical hysterectomy. Gynecol Oncol. 1997; 66(1):31-5. DOI: 10.1006/gyno.1997.4691. View

4.
Sarabhai T, Schaarschmidt B, Wetter A, Kirchner J, Aktas B, Forsting M . Comparison of F-FDG PET/MRI and MRI for pre-therapeutic tumor staging of patients with primary cancer of the uterine cervix. Eur J Nucl Med Mol Imaging. 2017; 45(1):67-76. DOI: 10.1007/s00259-017-3809-y. View

5.
Landoni F, Maneo A, Colombo A, Placa F, Milani R, Perego P . Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet. 1997; 350(9077):535-40. DOI: 10.1016/S0140-6736(97)02250-2. View